Search
for
Sort by
Research 61–90 of 1000+
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Idiopathic Hirsutism*
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Stauntonia hexaphylla Extract Ameliorates Androgenic Alopecia by Inhibiting Androgen Signaling in Testosterone-induced Alopecia Mice
- Androgenetic alopecia: pathogenesis and potential for therapy
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Androgen sensitivity gateway to COVID‐19 disease severity
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- 25 years of ERβ: a personal journey
- Alopecia - the search for novel agents continues
- A novel actor in skin biology: the mineralocorticoid receptor
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Hair aging and anti-aging
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Bioavailability File: Bicalutamide
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague–Dawley Rats
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Antiandrogen therapy for androgenetic alopecia
- Roles of steroid receptors in the lung and COVID-19
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Medical Management Options for Hair Loss
- Male‐pattern baldness, common latent viruses, and microcompetition
- Skin manifestations of hyperandrogenism: an update